Published in Gene Therapy Weekly, February 13th, 2003
According to Hui Wang and colleagues at the University of Alabama at Birmingham, prostate cancer and many other cancers overexpress MDM2 oncogene. However, MDM2 antisense oligonucleotides can prevent prostate cancer growth even when p53 expression is not normal.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.